Document is current
Any future updates will be listed below
-
Authors
Nikesjö, Frida
Smiljanić, Jelena
Sayyab, Shumaila
Martínez-Enguita, David
Gustafsson, Mika
Rosvall, Martin
Hedman, Kristofer
Lerm, Maria
-
Funding
Funding for this research was provided by:
Linköping University
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 20 February 2026
First Online: 11 March 2026
Declarations
:
: The study was conducted in accordance with the principles of the Declaration of Helsinki and was approved in April 2021 by the Swedish Ethical Review Authority (Dnr. 2021 − 01620). Written informed consent was obtained from all participants prior to study participation.
: Not applicable.
: ML, MG, SS and DM are founders of a company, which has the ambition to develop DNAm-based biomarkers for a variety of conditions, including PCC. The other authors declare no competing interests.
